Alzamend Neuro (ALZN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ALZN Alzamend Neuro

Watchlist

1.2500
-0.0500-3.85%

Close Dec 2 16:00 ET

1.3600
+0.1100+8.80%

Post 20:01 ET

5.59MMarket Cap-118P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Alzamend Neuro Inc: Both Treatments Had No Negative Impact on Mice's Body Weight or Clinical Signs During Treatment Period
ReutersNov 19 08:03 ET
Express News | Alzamend Neuro Inc: At a Low Dose, Al001 Evidenced Consistently Higher Lithium Concentrations Than Lithium Carbonate Within Critical Brain Regions
ReutersNov 19 08:02 ET
Alzamend Neuro Announces Full Data Set From Its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures Between AL001 and Lithium Carbonate in Alzheimer's Transgenic Mice
BusinesswireNov 19 08:00 ET
Express News | Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $35
BenzingaNov 11 04:35 ET
Alzamend Neuro Analyst Ratings
BenzingaNov 11 04:33 ET · Ratings
Express News | Alzamend Neuro Inc - to Initiate Five Clinical Trials Based on Study Results
ReutersOct 16 08:04 ET

Comments

Teo knows

Nov 11 04:02

$Alzamend Neuro (ALZN.US)$ why this drop ??

Trytosaveabit

Oct 16 06:41

A Bit More

$Alzamend Neuro (ALZN.US)$ Alzamend Neuro Tells Benzinga 'Data Confirm the Positive Topline Results Announced in June 2023 Identifying a Maximum Tolerated Dose as Assessed by an Independent Safety Review Committee'!
Alzamend Neuro Tells Benzinga 'Identified Dose Is Unlikely to Require Lithium Therapeutic Drug Monitoring'

Trytosaveabit

Oct 16 06:32

News

$Alzamend Neuro (ALZN.US)$ EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's
Benzinga· just
On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) said it received the final full data set from its multiple ascending dose clinical trial for AL001 for dementia related to Alzheimer's. Preliminary results were released in June 2023.
Identified by an independent safety review committee, this MTD represents a pivotal ...

frogoracletrading

Aug 31 12:21

$ALZN Support / Resistance Levels

Worth keeping an eye on for a bounce next week. If the top of the GAP holds 2.22 then look for a move to test 2.98 and beyond.
Larger Image: tradingview.com...
$Alzamend Neuro (ALZN.US)$